493 related articles for article (PubMed ID: 33596235)
1. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
Freidel MR; Armen RS
PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng ET; Vatandaslar H; Chait BT; Kapoor TM; Darst SA; Campbell EA
Cell; 2020 Sep; 182(6):1560-1573.e13. PubMed ID: 32783916
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
[TBL] [Abstract][Full Text] [Related]
4. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
[TBL] [Abstract][Full Text] [Related]
5. Architecture of a SARS-CoV-2 mini replication and transcription complex.
Yan L; Zhang Y; Ge J; Zheng L; Gao Y; Wang T; Jia Z; Wang H; Huang Y; Li M; Wang Q; Rao Z; Lou Z
Nat Commun; 2020 Nov; 11(1):5874. PubMed ID: 33208736
[TBL] [Abstract][Full Text] [Related]
6. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
[TBL] [Abstract][Full Text] [Related]
7. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
[TBL] [Abstract][Full Text] [Related]
8. The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
Zheng T; Shen B; Bai Y; Li E; Zhang X; Hu Y; Gao T; Dong Q; Zhu L; Jin R; Shi H; Liu H; Gao Y; Liu X; Cao C
J Virol; 2024 Apr; 98(4):e0156523. PubMed ID: 38445884
[TBL] [Abstract][Full Text] [Related]
9. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets.
Subissi L; Imbert I; Ferron F; Collet A; Coutard B; Decroly E; Canard B
Antiviral Res; 2014 Jan; 101():122-30. PubMed ID: 24269475
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
[TBL] [Abstract][Full Text] [Related]
12. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.
Shahid M; Shahzad-Ul-Hussan S
J Struct Biol; 2021 Mar; 213(1):107690. PubMed ID: 33383190
[TBL] [Abstract][Full Text] [Related]
13. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
Di Paco G; Macchiagodena M; Procacci P
ChemMedChem; 2024 May; 19(10):e202400095. PubMed ID: 38456332
[TBL] [Abstract][Full Text] [Related]
15. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
Jung LS; Gund TM; Narayan M
Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
Showers WM; Leach SM; Kechris K; Strong M
Infect Genet Evol; 2022 Jan; 97():105153. PubMed ID: 34801754
[TBL] [Abstract][Full Text] [Related]
19. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
Yan L; Ge J; Zheng L; Zhang Y; Gao Y; Wang T; Huang Y; Yang Y; Gao S; Li M; Liu Z; Wang H; Li Y; Chen Y; Guddat LW; Wang Q; Rao Z; Lou Z
Cell; 2021 Jan; 184(1):184-193.e10. PubMed ID: 33232691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
